Therapure Biopharma has launched its plasma products and technology division as Evolve Biologics. Evolve’s leadership team consists of chief executive officer Blaine Forshage; chief commercial officer, David Holliday; and chief financial officer, Gregory Gould. “Today we publicly launch our strategy to realize the value in Therapure’s proven technology and team, through a company dedicated to the development of plasma-derived therapeutics for patients with rare chronic di...